Accessibility to antibodies of acetylcholine receptors in the neuromuscular junction.
- 1 April 1976
- journal article
- Vol. 24 (1), 9-17
Abstract
Antibodies to the acetylcholine receptor are present in the serum of myasthenic patients but one does not know if, in vivo and in situ, they can penetrate the intact neuromuscular junction and block directly the receptor. The present experiments demonstrate that molecules the size of antibodies can reach acetylcholine receptor in situ. The mouse diaphragm with its intact neuromuscular junction was used as a source of acetylcholine receptor. The receptor was revealed either directly by iodinated alpha-bungarotoxin covalently coupled to IgG or indirectly, once labelled with cobra toxin, by iodinated anti-cobra toxin antibodies.This publication has 27 references indexed in Scilit:
- Immunoperoxidase staining of α-bungarotoxin binding sites in muscle endplates shows distribution of acetylcholine receptorsNature, 1975
- The acetylcholine receptor: Progress reportLife Sciences, 1974
- Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine ReceptorsScience, 1973
- Molecular properties of the cholinergic receptor purified from Electrophorus electricusBiochemistry, 1973
- Immunological characterisation of the cholinergic receptor protein from Electrophorus electricusFEBS Letters, 1973
- Isolation of the nicotinic acetylcholine receptor by biospecific chromatography on insolubilized Naja naja neurotoxinFEBS Letters, 1972
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962
- Efficient Trace-labelling of Proteins with IodineNature, 1958
- Autoradiography of End-plates with Carbon-14 – Calabash – Curarine I and Carbon-14 – DecamethoniumNature, 1956